COVID-19 Self-Tests Could Hit German Retail Shelves In A Matter Of Weeks
In Germany, a draft reguation circulated to industry associations proposes the sale of COVID-19 antigen tests directly to the public. If the amendment to Germany's medical devices regulations is approved, the onus will be on manufacturers to submit viable tests for approval, with the country's in-vitro testing industry association suggesting that this could be achieved in a matter of weeks.
You may also be interested in...
Roche's new CE-marked nasal-swab antigen test could be a good candidate for approval within Germany's recently liberalized COVID-19 self-test market.
BinaxNOW rapid tests, the size of a credit card with no other equipment required, are sold directly to organizations at $5 each and an at-home version, with use guided through digital links, is available at $25 per test. It can be paired with NAVICA app, allowing consumers to display negative results through a temporary digital health certificate.
Commercial COVID-19 antibody self-tests are back on the agenda in Europe, this time in Germany, where the Greens are calling for amendments to the country's medical devices regulations to allow tests to be sold OTC in pharmacies and incentives for industry to quickly scale up production.